FDA drug quality assurance inspections: frequency, outcomes, and time to reinspection, 2008-2025.

Sun Y, Ballreich J, Acha J, Modi R, Alamdar Yazdi MA, Dada M, Dai T, Anderson G, Socal MP

Open source

DOI
10.1093/haschl/qxag229
Published
2026 Sep
Container
Health affairs scholar
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/haschl/qxag229,
  title = {FDA drug quality assurance inspections: frequency, outcomes, and time to reinspection, 2008-2025.},
  author = {Sun Y and Ballreich J and Acha J and Modi R and Alamdar Yazdi MA and Dada M and Dai T and Anderson G and Socal MP},
  year = {2026},
  journal = {Health affairs scholar},
  doi = {10.1093/haschl/qxag229},
  url = {https://doi.org/10.1093/haschl/qxag229}
}

RIS

TY  - JOUR
TI  - FDA drug quality assurance inspections: frequency, outcomes, and time to reinspection, 2008-2025.
AU  - Sun Y
AU  - Ballreich J
AU  - Acha J
AU  - Modi R
AU  - Alamdar Yazdi MA
AU  - Dada M
AU  - Dai T
AU  - Anderson G
AU  - Socal MP
PY  - 2026
JO  - Health affairs scholar
DO  - 10.1093/haschl/qxag229
UR  - https://doi.org/10.1093/haschl/qxag229
ER  - 

APA

Y, S., J, B., J, A., R, M., MA, A. Y., M, D., T, D., G, A., & MP, S. (2026). FDA drug quality assurance inspections: frequency, outcomes, and time to reinspection, 2008-2025.. Health affairs scholar. https://doi.org/10.1093/haschl/qxag229

Source records